Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases.
The company announced on 4 March 2026 that it had reached an agreement with two strategic US-based biodefence institutions in connection with ILA’s Galidesivir programme.
The three-year Cooperative Research and Development Agreement (CRADA) is a trilateral agreement with the US Army Medical Research Institute (USAMRIID) and The Geneva Foundation.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
Island Pharmaceuticals Ltd - Aligning with the US Government